Current Phase II clinical data for ridaforolimus in cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1485-1493

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art

By Lheureux Stephanie Wilson Michelle Mackay Helen J

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 773-792

Informa Healthcare

Access to resources Recommend Favorite

Ridaforolimus

Drugs in R&D, Vol. 10, Iss. 3, 2010-09 ,pp. : 165-178

Adis International

Access to resources Recommend Favorite

SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group

By Wong R. Baetz T. Krahn M. Biagi J. Wainman N. Eisenhauer E.

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 347-351

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Phase II Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

Dalcetrapib: a review of Phase II data

By Robinson Jennifer G

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 795-805

Informa Healthcare

Access to resources Recommend Favorite